EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiproliferative and Proapoptotic Effects of Chetomin in Human Melanoma Cells

Laura Jonderko iD, Anna Choromańska iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Laura Jonderko und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, Poland. Hauptthemen laut MEDLINE: Apoptosis, Cell Proliferation, Melanoma, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Molecular and Cellular Biology of Wroclaw Medical University, Statutory Subsidy Funds of the Department of Molecular and Cellular Biology of Wroclaw Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is an aggressive malignancy with poor prognosis in advanced stages, and current therapeutic options provide only limited benefits, highlighting the need for novel treatments. Chetomin, a fungal metabolite isolated from Chaetomium cochliodes, has been reported to exhibit diverse biological activities, yet its effects on melanoma cells remain poorly understood. In this study, we evaluated the antitumor potential of chetomin using the human A375 melanoma cell line. Cell viability was assessed with MTT and CellTiter-Glo® assays, which revealed a significant dose- and time-dependent reduction in proliferation following chetomin exposure. Apoptotic effects were confirmed through Annexin V staining, and immunocytochemical analysis demonstrated a concentration-dependent increase in cleaved PARP1, indicating activation of programmed cell death pathways. Collectively, these findings demonstrate that chetomin effectively inhibits melanoma cell growth and promotes apoptosis. The results suggest that chetomin represents a promising lead compound for melanoma therapy, warranting further investigation into its precise molecular mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisCell ProliferationMelanomaAntineoplastic AgentsIndole AlkaloidsHumansCell Line, TumorCell SurvivalPoly (ADP-Ribose) Polymerase-1Chaetomium

Stichwörter der Autor:innen

A375 cellsapoptosiscell proliferationchetominfungal metabolitemelanomanatural product

Substanzen

Antineoplastic AgentsPoly (ADP-Ribose) Polymerase-1Indole Alkaloids

Autor:innen und Institutionen

  • Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, Poland.

ORCID-Profile: Laura Jonderko, Anna Choromańska

Förderung

  • Department of Molecular and Cellular Biology of Wroclaw Medical University
  • Statutory Subsidy Funds of the Department of Molecular and Cellular Biology of Wroclaw Medical University

Zitieren

APA

Jonderko, L., & Choromańska, A. (2025). Antiproliferative and Proapoptotic Effects of Chetomin in Human Melanoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199835

Vancouver

Jonderko L, Choromańska A. Antiproliferative and Proapoptotic Effects of Chetomin in Human Melanoma Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199835

BibTeX
@article{Jonderko2025,
  author = {Jonderko, Laura and Choromańska, Anna},
  title = {Antiproliferative and Proapoptotic Effects of Chetomin in Human Melanoma Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199835}
}
Kostenlos starten →